APA (7th ed.) Citation

SM, M., B, C., C, C., HM, C., J, D., MT, L., . . . SE, K. (2026). Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: A prespecified analysis of the SELECT randomized trial. Nature medicine, 32(5), 1686. https://doi.org/10.1038/s41591-026-04281-1

Chicago Style (17th ed.) Citation

SM, Meyhöfer, et al. "Semaglutide on Liver Fibrosis and Heart Outcomes in Patients at High Risk of Liver Fibrosis: A Prespecified Analysis of the SELECT Randomized Trial." Nature Medicine 32, no. 5 (2026): 1686. https://doi.org/10.1038/s41591-026-04281-1.

MLA (9th ed.) Citation

SM, Meyhöfer, et al. "Semaglutide on Liver Fibrosis and Heart Outcomes in Patients at High Risk of Liver Fibrosis: A Prespecified Analysis of the SELECT Randomized Trial." Nature Medicine, vol. 32, no. 5, 2026, p. 1686, https://doi.org/10.1038/s41591-026-04281-1.